Squalestatin alters the intracellular trafficking of a neurotoxic prion peptide
2007
Squalestatin's Effect on Neurotoxic Prion Peptide Trafficking
publication
Evidence: moderate
Author Information
Author(s): Wilson Rona, Bate Clive, Boshuizen Ronald, Williams Alun, Brewer James
Primary Institution: University of Glasgow
Hypothesis
The neurotoxicity of the prion peptide MoPrP105-132 is dependent on its intracellular trafficking pathways.
Conclusion
Squalestatin treatment alters the trafficking of the neurotoxic prion peptide, leading to increased cell survival.
Supporting Evidence
- MoPrP105-132 co-localised with lipid raft markers and trafficked intracellularly within lipid rafts.
- Squalestatin treatment reduced neuronal cholesterol levels and altered the peptide's trafficking.
- Treatment with squalestatin increased cell survival by rerouting the peptide to lysosomes.
Takeaway
This study shows that a drug called squalestatin can change how a harmful protein moves inside brain cells, helping the cells survive better.
Methodology
The study used fluorescence microscopy and cell fractionation techniques to analyze the trafficking of the MoPrP105-132 peptide in neuroblastoma cells.
Statistical Information
Statistical Significance
p>0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website